Clinical trials
Clinical Trials clinical trials
Below are recruiting clinical trials clinical trials, each written for real people, not researchers. We’re tracking 1,081 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06156800Recruiting
Radiation before biopsy in advanced cancer
This trial tests whether it is safe and effective to start radiation therapy before getting a tissue biopsy for patients with advanced or metastatic cancer that needs urgent treatment. It aims to avoid delays in care while still allowing for a biopsy later.
London, OntarioAges 18 years+ - NCT06184542RecruitingPhase 1
New DTaP vaccine safety trial for children
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
Dazhou, SichuanAges 2 months–6 years - NCT06187311RecruitingPhase 4
Rivaroxaban for atrial fibrillation patients
This trial tests two doses of rivaroxaban (15mg and 20mg) to see how well they prevent strokes in people with non-valvular atrial fibrillation, a type of irregular heartbeat not caused by a heart valve problem. It may be an option if you need blood thinners to lower your stroke risk.
SeoulAges 19–99 - NCT06194656RecruitingPhase 2
Trial of SIBP-03 for advanced head and neck cancer
This trial tests a new drug called SIBP-03 for people with head and neck squamous cell carcinoma that has come back or spread. It is for those whose cancer has worsened after prior immunotherapy and platinum chemotherapy, and who have no option for curative local treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06207071Recruiting
DHA and ARA supplements for small preterm babies
This trial tests whether giving early supplements of DHA and ARA (nutrients important for brain and eye development) to very small premature infants can improve health outcomes.
Birmingham, AlabamaAges 1 day–3 days - NCT06208332RecruitingPhase 2
Communication support for kids with severe neurological needs
This study tests a new communication program to help families and doctors talk about what matters most to your child with a severe neurological condition. It is for hospitalized children ages 6 months to 25 years old, who have had their condition for more than 6 months.
Seattle, WashingtonAges 6 months+ - NCT06208709Recruiting
Carpal tunnel treatment for right hand without surgery
This study tests a new way to treat carpal tunnel syndrome in the right hand without surgery. It may help people with mild to moderate symptoms who have not had recent injections or other treatments.
Tucson, ArizonaAges 18 years+ - NCT06215495Recruiting
New radiation target method for high-grade glioma
This study is testing a new way to target radiation for people with high-grade gliomas (aggressive brain tumors). The goal is to see if a more precise treatment plan can improve outcomes while keeping side effects low.
GuangzhouAges 18–65 - NCT06221709Recruiting
Radiofrequency for hip arthritis pain: a clinical trial
This trial tests whether a treatment called continuous radiofrequency can reduce pain from hip arthritis. It is for people with moderate arthritis in one hip who have had pain for more than six months.
Brasília, Federal DistrictAges 18 years+ - NCT06224816Recruiting
Custom 3D-printed nasal masks for premature babies on breathing support
This trial tests whether custom 3D-printed nasal masks work better for premature babies who need non-invasive breathing support. The masks are made to fit each baby's face, which might be more comfortable and effective.
MadridAges birth–4 weeks - NCT06228794Recruiting
CPC blood test to predict multiple myeloma outcomes
This trial is studying a new blood test that measures circulating plasma cells (CPCs) to help predict how multiple myeloma may progress. It is for people newly diagnosed with multiple myeloma who have not yet started treatment.
Wuhan, HubeiAges 18–80 - NCT06234124Recruiting
A shoe to improve walking after stroke
This study tests a special shoe that changes friction to help improve walking for people who have had a stroke. It lasts 6 months and involves daily exercises at home.
Chicago, IllinoisAges 18 years+ - NCT06237816Recruiting
Clinical trials education program for rural cancer patients
This study is testing a program that teaches cancer patients and their doctors about clinical trials. It is designed for people living in rural areas of Hawaii and may help you learn more about treatment options.
Hilo, HawaiiAges 18 years+ - NCT06241599RecruitingPhase 2/Phase 3
AK104 with chemo for advanced nasopharyngeal cancer
This study tests if adding a new immunotherapy drug (called AK104) to standard chemotherapy can help people whose nasopharyngeal cancer has come back or spread after previous treatment. The goal is to see if the combination works better than chemotherapy alone.
Guangzhou, GuangdongAges 18–75 - NCT06241755RecruitingPhase 3
BCG to prevent bladder cancer return after surgery
This study tests if BCG therapy can prevent bladder cancer from coming back after surgery. It's for people with early-stage bladder cancer that hasn't spread into the muscle layer.
Guangzhou, GuangdongAges 18–75 - NCT06243614RecruitingPhase 3
Testing buagafuran capsules for generalized anxiety disorder
This trial tests a new medication called buagafuran for people with generalized anxiety disorder (GAD). It aims to see if the drug can safely reduce anxiety symptoms.
Beijing, Beijing MunicipalityAges 18–65 - NCT06243640RecruitingPhase 3
New capsule for generalized anxiety disorder trial
This trial tests a new capsule called Buagafuran for adults with generalized anxiety disorder (GAD). It aims to see if the medication helps reduce anxiety without causing major side effects.
Beijing, Beijing MunicipalityAges 18–65 - NCT06252961RecruitingPhase 2/Phase 3
Testing levamisole for loiasis infection
This trial tests if a medicine called levamisole can safely reduce the number of loiasis (eye worm) parasites in your blood. You would take the medicine for 3 to 5 days and be monitored.
Sibiti, KomonoAges 18–65 - NCT06258512Recruiting
Storytelling approach for frequent doctor visits
This trial tests if a storytelling-based conversation can help people who visit their primary care doctor very often. If you are one of the top frequent visitors to your clinic, this study may help you feel better and reduce your need for appointments.
Barcelona, CataloniaAges 25–85 - NCT06267989Recruiting
Early treatment for misplaced upper canine teeth
This trial tests whether early treatment can help guide a misplaced upper permanent canine tooth into its correct position. It may be a good option if your canine tooth is not coming in normally and is not pushed toward the cheek.
Traben-TrarbachAges 10–12 - NCT06270537Recruiting
Dominus stent-graft follow-up study
This study is checking how well the Dominus stent-graft works over time in people who have already had it placed. You may be asked to come back for follow-up visits.
Vila Velha, Espírito SantoAges 18 years+ - NCT06272149RecruitingEarly Phase 1
Gene Therapy for Infants With Type 2 Gaucher Disease
This trial tests a new gene therapy (VGN-R08b) for infants with Type 2 Gaucher disease, a rare genetic condition that affects the brain and body. The goal is to see if the treatment is safe and can help improve symptoms.
Shanghai, Shanghai MunicipalityAges birth–2 years - NCT06283745Recruiting
Platelet-rich plasma nasal injection for smell distortion
This trial tests whether injecting a concentrated part of your own blood (platelet-rich plasma) into your nose can help improve a distorted sense of smell called parosmia. You will also do smell training at home, which is the current standard care.
Palo Alto, CaliforniaAges 18 years+ - NCT06290661Recruiting
Nerve stimulation for shingles-related nerve pain
This study tests a treatment called peripheral nerve stimulation (using a small device to send mild electrical pulses) for people with nerve pain after shingles. It's designed for those whose pain is not well managed by usual treatments.
Wuhan, HubeiAges 18 years+
Hear when a new Clinical Trials trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical trials?
- Yes. Clin2 currently lists 1,081 recruiting clinical trials studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trials trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trials trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Clinical Competence
- Clinical High Risk for Psychosis (CHR)
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage III Gastric Cancer AJCC v8
- Clinical Stage III Esophageal Adenocarcinoma AJCC v8
- Clinical Stage IV Gastric Cancer AJCC v8
- Clinical Decision Support
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.